Tag Archives: David Kideckel

HEXO Corporation (HEXO) Gets a Buy Rating from AltaCorp Captial

On June 14, an analyst has provided a rating update for HEXO Corporation (HEXO – Research Report). Analyst David Kideckel from AltaCorp Captial remains bullish on the stock and has a C$10.40 price target. According to TipRanks.com, Kideckel is ranked

AltaCorp Captial Sticks to Their Buy Rating for GW Pharma (GWPH)

AltaCorp Captial analyst David Kideckel reiterated a Buy rating on GW Pharma (GWPH – Research Report) yesterday and set a price target of $221. The company’s shares opened today at $185.54, close to its 52-week high of $196. Kideckel has

AltaCorp Captial Believes Valens Groworks Corp (CNQX: VGW) Won’t Stop Here

The Healthcare company, Valens Groworks Corp (VGW – Research Report), has received a rating update from a Wall Street analyst on April 25. On April 25, analyst David Kideckel gave a Buy rating to VGW and set a C$7.75 price